Bioanalysis

Papers
(The H4-Index of Bioanalysis is 14. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Meet the Editorial Board – An Interview with Min Meng and Transitions from Small Regional Labs to Global CRO46
Biomonitoring of Arsenic, Lead, Manganese and Mercury in Hair from a Presumably Exposed Uruguayan Child Population26
Volumetric Absorptive Microsampling as An Effective Microsampling Technique for LC–MS/MS Bioanalysis of Biomarkers in Drug Discovery24
MS-DIAL pre-processing for mining schistosomiasis metabolites in urine samples from the Okavango Delta of Botswana from a GC-MS dataset20
Bioanalysis by LC-MS/MS and Preclinical Pharmacokinetic Interaction Study of Ribociclib and Oleanolic Acid19
Adopting ambient ionization mass spectrometry into bioanalytical laboratories19
A validated UHPLC-MS/MS method for determination of BPI-43487 and its metabolite BPI-43739 in human plasma and its application to a pharmacokinetic study in Chinese patients with advanced solid tumors18
Uncovering the Green Frontier: Harnessing Deep Eutectic Solvents for Sustainable Bioanalysis17
A fully automated novel solid-phase extraction method for siRNA drug extraction and quantitation across multiple tissues using LC-MS17
2025 White Paper on Recent Issues in Bioanalysis: Biomarkers Calibrators & Stability; Evaluation of NULISA; Neurofilament & Autoantibody Biomarker Assays; Removing IgM Interference; ELISpot &a16
Peripheral blood mononuclear cells isolation from mouse and rabbit blood to quantify active nucleotide and define brincidofovir dose for smallpox15
Biomarker Context-Of-Use: How Organizational Design Can Impact the Implementation of the Appropriate Biomarker Assay Strategy15
Patient centric blood sampling and analysis for diagnostics and laboratory medicine14
The complexities of oligonucleotide therapeutics: analytical challenges and opportunities within early drug discovery14
0.1367461681366